Case File
efta-efta00847294DOJ Data Set 9OtherFrom: "Barrett, Paul S" <
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00847294
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: "Barrett, Paul S" <
To: Brad Wechsler <
CC: "Jeffrey E 'stein ticevacation(&email.com)" jeevacationggmail.com>, "Rich Joslin
--, Barrett Team
Subject: Merck Structured Note
Date: Tue, 01 Sep 2015 18:25:28 +0000
Attachments: image005.emz; image007.emz
Inline-Images: image006.png; image008.png
Brad
I believe the following indicative terms of a hypothetical trade idea may be attractive to you. While these terms cannot
substitute a prospectus, and do not yield enough information to make an investment decision, I think they are worth
discussing further.
Implementation Vehicle
Structured Product (CBEN*)
Tenor
[52-54) weeks
Coupon
3.00%
Cap
[13-151%
Upside Partic./Adj. Factor
100%
Protection (%)
(80 - 821%
Protection (Type)
Contingent, At Maturity
Callable
N/A
Other Features
*CBEN is an acronym for Contingent Buffered Enhanced Note.
Indicative pricing terms as of (9/1/20151, based on assumed notionals of [US$ 5 - 10mm]. Actual terms subject to market
conditions at the time of execution.
IMPORTANT INFORMATION
This e-mail is for discussion purposes only. It is not intended as investment advice, a recommendation or an offer or
solicitation for the purchase or sale of a specific financial instrument. The information in this e-mail is not complete
and any offering of a specific financial instrument will be made only by appropriate offering documentation..
Morgan is under no obligation to enter into any transaction with you on any of the indicative terms herein, or at all.
Any comments or statements in this e-mail do not necessarily reflect those of
Morgan and its affiliates, including
the U Morgan Research Department.
s Free Writing Prospectus
This e-mail contains non-binding indicative pricing terms, which have been prepared by.. Morgan using our standard
methodologies for quotations of this kind. We take no responsibility for the accuracy, completeness or appropriateness
of these methodologies. The actual historical data and indicative price quotations herein are as of a particular date and
time only and may change without notice.. Morgan is under no obligation to update the information in this e-mail.
Actual terms of any transaction will be subject to market conditions at the time of execution. The example is for
illustrative purposes only and should never be implied as a guaranteed return or performance.
Structured products are complex debt obligations of a corporate issuer the return of which is linked to the performance
of an underlying asset. They are significantly riskier than conventional debt instruments and may not be suitable for all
EFTA00847294
investors. Such risks include risk of adverse or unanticipated market developments, issuer credit quality risk, risk of
counterparty or issuer default, risk of lack of uniform standard pricing, risk of adverse events involving any underlying
reference obligations, entity or other measure, risk of high volatility, of risk of illiquidity and little to no secondary
market. In certain transactions, investors may lose their entire investment or incur an unlimited loss. You should only
purchase a structured product after review of the relevant offering documents, which contain important information
concerning the terms of the product, the risk factors, and other material information.
Each issuer will file a registration statement (including a prospectus) with the SEC for the offering to which this
communication relates. Before you invest, you should read the prospectus in that registration statement and other
documents the issuer will file with the SEC for more complete information about the issuer and this offering. You may
get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any
underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by
calling me at my number below.
With respect to countries in Latin America, the distribution of this material may be restricted in certain jurisdictions. Receipt
of this material does not constitute an offer or solicitation to any person in any jurisdiction in which such offer or solicitation
is not authorized or to any person to whom it would be unlawful to make such offer or solicitation.
Morgan Private Bank" is a marketing name for private banking business conducted by JPMorgan Chase & Co. and its
subsidiaries worldwide. Securities products and services are offered by
Morgan Securities LLC. Member NYSE, FINRA
and SIPC. Bank products and services are offered by JPMorgan Chase Bank, •.
and its bank affiliates.
..INVESTMENT PRODUCTS: NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege,
and legal entity disclaimers, available at
EFTA00847295
Technical Artifacts (5)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
email.comDomain
jeevacationggmail.comDomain
www.sec.govSWIFT/BIC
PRODUCTSWire Ref
referenceRelated Documents (6)
DOJ Data Set 9OtherUnknown
From: "Jeffrey E." <[email protected]>
2p
DOJ Data Set 11OtherUnknown
EFTA02482909
1p
DOJ Data Set 11OtherUnknown
EFTA02504647
1p
DOJ Data Set 9OtherUnknown
From: Brad Wechsler <1
1p
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA01732180
0p
DOJ Data Set 11OtherUnknown
EFTA02476274
3p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.